Company profile: Sestina Bio
1.1 - Company Overview
Company description
- Provider of automated synthetic biology platforms and gene-editing tools to sustainably feed, clothe, and treat the world's population, including the GenoScaler™ Platform for automated synthetic biology and the MAD7® Nuclease for precise genome modifications.
Products and services
- GenoScaler™ Platform: An automated synthetic biology platform engineered to help sustainably feed, clothe, and treat the world's population
- Technology-Centric R&D Platform: A technology-centric R&D platform that integrates and, where needed, creates innovative systems to sustainably feed, clothe, and keep healthy the growing world population
- MAD7® Nuclease: An enzyme-based gene-editing nuclease employed within automated synthetic biology programs to enable precise genome modifications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sestina Bio
Interleukin Genetics
HQ: United States
Website
- Description: Provider of genetic tests for the emerging personalized health market, using applied genetics to empower individuals to personalize their health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interleukin Genetics company profile →
HomeDNA
HQ: United States
Website
- Description: Provider of a home paternity test kit; a pharmaceutical firm.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HomeDNA company profile →
Ultima Genomics
HQ: United States
Website
- Description: Provider of a low-cost sequencing platform and related workflows, including the UG 100™ high-throughput system using a 200mm open silicon wafer with built-in automation; ppmSeq™ for rare event detection at one part per million for liquid biopsies and MRD; large-scale single-cell and spatial sequencing workflows; RNA-Seq for gene expression and isoform analysis; and genome-wide methylation sequencing compatible with standard tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ultima Genomics company profile →
NXT-Dx
HQ: Belgium
Website
- Description: Provider of epigenetics services from a private company led by an experienced team combining skills in epigenetics, transcriptomics, proteomics, and bioinformatics research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NXT-Dx company profile →
Medicinal Genomics
HQ: The Netherlands
Website
- Description: Provider of genomics-driven testing and breeding solutions for medical cannabis and hemp, including the PathoSEEK qPCR-based microbial safety testing platform and detection assays for flower, extracts, and infused products; SenSATIVAx DNA purification kits; FemINDICAtor qPCR plant sex testing; and genomic services to identify markers for desirable traits and accelerate breeding programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicinal Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sestina Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sestina Bio
2.2 - Growth funds investing in similar companies to Sestina Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sestina Bio
4.2 - Public trading comparable groups for Sestina Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →